Biotech

All Articles

Sanofi pays for $110M upfront for late-stage radioligand treatment

.Sanofi has actually brought in an overdue entrance to the radioligand event, paying one hundred tho...

F 2G raises $100M for second attempt to get brand-new antifungal to market

.After F2G's very first effort to get a new class of antifungal to market was wrecked by the FDA, th...

Moderna targets $1.1 B in R&ampD costs cuts, drops 5 courses in the middle of success tensions

.Moderna has actually vowed to cut R&ampD spending through $1.1 billion by 2027. The decision to shr...

Sanofi's $80M bank on Fulcrum dystrophy medication ends in phase 3 crash

.Merely 4 months after Sanofi wager $80 million in beforehand cash on Key Therapies' losmapimod, the...

Oncternal stock sinks 60% surrounded by layoffs, trial terminations

.Cancer cells company Oncternal Therapies is folding all its professional tests and giving up team, ...

Roche is holding out chances that its injectable weight problems prospect might eventually display 25% weight-loss in late-stage trial

.Roche is holding out chances that its own injectable weight problems prospect could at some point s...

Novo Nordisk barrages 'remarkable' fat burning result for dual-acting dental medication in very early test

.Novo Nordisk has actually lifted the cover on a period 1 trial of its own oral amylin and also GLP-...

AbbVie files suit BeiGene over blood stream cancer cells medication proprietary knowledge

.Just a handful of short full weeks after winning an FDA Fast Track tag for its investigational BTK ...

Lilly provides one-two strike with 2nd tranche of good records on every week blood insulin candidate

.Shortly after a positive data drop for Eli Lilly's efsitora alfa, the Indianapolis-based firm is on...

BridgeBio reduces gene treatment budget plan as scientific data let down

.BridgeBio Pharma is slashing its own gene treatment budget plan and also drawing back from the moda...